Changchun High-Tech Industry (000661.SZ): Application for clinical trial of GenSci143 for injection accepted.
Changchun High-tech (000661.SZ) announcement, the company's subsidiary - Changchun Jinsai Pharmaceutical Co., Ltd. ("Jinsai...
Changchun High-Tech Industry (000661.SZ) announced that its subsidiary, Changchun GenSci Pharmaceutical Co., Ltd. ("GenSci Pharmaceutical"), has received a written notification from the Food and Drug Administration of the United States (FDA) that its clinical trial application for injection of GenSci143 has been accepted, with indications for late-stage solid tumors.
Related Articles
Ganfeng Lithium Group (002460.SZ) granted authorization to dispose of a portion of the company's held stock assets.
Shenwan Hongyuan Group (06806): Shenwan Hongyuan Group issued 2.9 billion yuan of subordinated bonds.
In the first 9 months, DATANG RENEW (01798) accumulated a total electricity generation of approximately 25.89 billion kilowatt-hours, an increase of 11.68% compared to the same period last year.
Ganfeng Lithium Group (002460.SZ) granted authorization to dispose of a portion of the company's held stock assets.
Shenwan Hongyuan Group (06806): Shenwan Hongyuan Group issued 2.9 billion yuan of subordinated bonds.
In the first 9 months, DATANG RENEW (01798) accumulated a total electricity generation of approximately 25.89 billion kilowatt-hours, an increase of 11.68% compared to the same period last year.
RECOMMEND
